| Literature DB >> 23372914 |
Brijesh Thakur1, Vatsala Misra, Vishal Dhingra, Smita Chauhan.
Abstract
Pure myoepithelioma of breast is an extremely rare tumor. Only a few cases have been reported in the literature so far. A 30-year old female presented with a large fungating mass arising from the areolar region of her right breast of six months duration. A clinical diagnosis of breast carcinoma was made and a mastectomy was performed. The specimen measured 23×22×9 cm with attached skin, and showed a large white ulcerated growth with areas of necrosis and hemorrhage. No normal breast tissue, nipple or areolar region was seen. Histopathological examination showed oval to spindle cells arranged in fascicles and bundles with whorling pattern in places showing mild pleomorphism with oval to spindle-shaped vesicular nuclei, prominent eosinophilic nucleoli, eosinophilic cytoplasm and clear cell changes in places, along with perivascular hyalinization and collagenization. Differential diagnosis of pleomorphic hyalinizing angiectatic tumor, solitary fibrous tumor, perivascular epithelioid cell tumor, mammary type myofibroblastic tumor and myoepithelioma were all considered. Immunohistochemistry for vimentin, smooth muscle actin, calponin, caldesmon, p63, epithelial membrane antigen, S-100, CD-31, CD-34, muscle specific antigen, myogenin, desmin, and pancytokeratin was carried out. On the basis of positive staining for vimentin, actin, p63 (nuclear), calponin and caldesmon (focal), a final diagnosis of myoepithelioma was considered; however, cytokeratin negativity was an unusual finding. This case was considered worthy of documentation because of its rarity, and because it highlights the importance of proper clinical examination and radiological examination to prevent misdiagnosis.Entities:
Keywords: breast; cytokeratin.; myoepithelioma; p63
Year: 2012 PMID: 23372914 PMCID: PMC3557564 DOI: 10.4081/rt.2012.e50
Source DB: PubMed Journal: Rare Tumors ISSN: 2036-3605
Figure 1A) Specimen showing a large white ulcerated growth; B) inferior surface of specimen shows attached skin; C) spindle-shaped cells showing whorling pattern around blood vessels (Haematoxylin and Eosin 100×); D) spindle-shaped cells arranged in fascicles around blood vessels (Haematoxylin and Eosin 100×).
Figure 2A) Clear cell changes in spindle-shaped cells with prominent nucleoli (Haematoxylin and Eosin 400×); B) spindle-shaped cells showing eosinophilic cytoplasm and prominent nucleoli with clear cell changes at places (Haematoxylin and Eosin 400×); C) focal areas of hyalinization and collagenization (Haematoxylin and Eosin 100×); D) few compressed glands at the margin of tumor (Haematoxylin and Eosin 100×). Inset shows myoepithelial proliferation around a duct (400×).
Antibodies used.
| N. | Name | Clone | Company | Dilution |
|---|---|---|---|---|
| 1 | Vimentin | V9 | Dako | Ready to use |
| 2 | Smooth muscle actin | 1A4 | Dako | Ready to use |
| 3 | Calponin | BSB5/20 | Biosb | Ready to use |
| 4 | Caldesmon | h-CD | Dako | Ready to use |
| 5 | Epithelial membrane antigen | E29 | Dako | Ready to use |
| 6 | S-100 protein | Polyclonal | Dako | Ready to use |
| 7 | CD31 | JC70A | Dako | Ready to use |
| 8 | CD34 | QBEnd | Dako | Ready to use |
| 9 | Muscle specific antigen | HHF35 | Dako | Ready to use |
| 10 | Myogenin | F50 | Dako | Ready to use |
| 11 | Desmin | D33 | Dako | Ready to use |
| 12 | Pan CK | AE1/AE3 | Dako | Ready to use |
| 13 | Pan CK | MNF116 | Biogenex | Ready to use |
| 14 | P63 | 7JUL | Lieca | Ready to use |
Figure 3A) Diffuse cytoplasmic positivity for vimentin (400×); B) cytoplasmic positivity for smooth muscle actin (400×); C) nuclear immunopositivity for p63 (400×); D) focal positivity for calponin (400×); E) focal positivity for caldesmon (400×); F) CD34 positivity in blood vessel lining but negative in tumor cells (400×).
Immunoprofile of various tumors considered for differential diagnosis.
| Tumors | Vi | SMA | P63 | Cal | Cald | EMA | S100 | CD31 | CD34 | MSA | Myo | Des | Pan CK |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PHAT | + | - | - | NI | NI | - | - | - | + | NI | NI | - | - |
| SFT | + | - | - | + | NI | - | ± | - | + | NI | NI | NI | - |
| PEComa | + | + | - | NI | + | - | - | ± | ± | ± | ± | - | - |
| MFB | + | + | - | ± | ± | - | - | ± | ± | ± | ± | + | - |
| ME | ± | + | + | + | + | - | + | - | - | - | - | - | + |
NI, no information; PHAT, pleomorphic hyalinizing angiectatic tumor; SFT, Solitary fibrous tumor; PECOMA, Perivascular epithelioid cell tumor; MFB, myofibroblastoma; ME, myoepithelioma.